Literature DB >> 21862585

Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.

Dennis E Hourcade1, Lynne M Mitchell.   

Abstract

Factor B is a zymogen that carries the catalytic site of the complement alternative pathway C3 convertase. During convertase assembly, factor B associates with C3b and Mg(2+) forming a pro-convertase C3bB(Mg(2+)) that is cleaved at a single factor B site by factor D. In free factor B, a pair of salt bridges binds the Arg(234) side chain to Glu(446) and to Glu(207), forming a double latch structure that sequesters the scissile bond (between Arg(234) and Lys(235)) and minimizes its unproductive cleavage. It is unknown how the double latch is released in the pro-convertase. Here, we introduce single amino acid substitutions into factor B that preclude one or both of the Arg(234) salt bridges, and we examine their impact on several different pro-convertase complexes. Our results indicate that loss of the Arg(234)-Glu(446) salt bridge partially stabilizes C3bB(Mg(2+)). Loss of the Arg(234)-Glu(207) salt bridge has lesser effects. We propose that when factor B first associates with C3b, it bears two intact Arg(234) salt bridges. The complex rapidly dissociates unless the Arg(234)-Glu(446) salt bridge is released whereupon conformational changes occur that activate the metal ion-dependent adhesion site and partially stabilize the complex. The remaining salt bridge is then released, exposing the scissile bond and permitting factor D cleavage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862585      PMCID: PMC3195642          DOI: 10.1074/jbc.M111.263418

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 2.  T-cell regulation: with complements from innate immunity.

Authors:  Claudia Kemper; John P Atkinson
Journal:  Nat Rev Immunol       Date:  2006-12-01       Impact factor: 53.106

Review 3.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 4.  Complement and the multifaceted functions of VWA and integrin I domains.

Authors:  Timothy A Springer
Journal:  Structure       Date:  2006-11       Impact factor: 5.006

5.  Factor B structure provides insights into activation of the central protease of the complement system.

Authors:  Fin J Milder; Lucio Gomes; Arie Schouten; Bert J C Janssen; Eric G Huizinga; Roland A Romijn; Wieger Hemrika; Anja Roos; Mohamed R Daha; Piet Gros
Journal:  Nat Struct Mol Biol       Date:  2007-02-25       Impact factor: 15.369

Review 6.  The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.

Authors:  Michael A Flierl; Heike Schreiber; Markus S Huber-Lang
Journal:  J Invest Surg       Date:  2006 Jul-Aug       Impact factor: 2.533

7.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 8.  Atypical haemolytic uraemic syndrome.

Authors:  David Kavanagh; Timothy H J Goodship; Anna Richards
Journal:  Br Med Bull       Date:  2006-09-11       Impact factor: 4.291

9.  Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).

Authors:  Claire L Harris; Rachel J M Abbott; Richard A Smith; B Paul Morgan; Susan M Lea
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

10.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

View more
  6 in total

1.  Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Authors:  Serena Bettoni; Elena Bresin; Giuseppe Remuzzi; Marina Noris; Roberta Donadelli
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

2.  Anti-complement activity of the Ixodes scapularis salivary protein Salp20.

Authors:  Dennis E Hourcade; Antonina M Akk; Lynne M Mitchell; Hui-fang Zhou; Richard Hauhart; Christine T N Pham
Journal:  Mol Immunol       Date:  2015-12-08       Impact factor: 4.407

3.  Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.

Authors:  Sigridur Sunna Aradottir; Ann-Charlotte Kristoffersson; Lubka T Roumenina; Anna Bjerre; Pavlos Kashioulis; Runolfur Palsson; Diana Karpman
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

4.  Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.

Authors:  Loveleena Bansal; Eva-Maria Nichols; Daniel P Howsmon; Jessica Neisen; Christina M Bessant; Fraser Cunningham; Sebastien Petit-Frere; Steve Ludbrook; Valeriu Damian
Journal:  Front Pharmacol       Date:  2022-04-19       Impact factor: 5.988

5.  Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.

Authors:  Roberta Donadelli; Patrizia Pulieri; Rossella Piras; Paraskevas Iatropoulos; Elisabetta Valoti; Ariela Benigni; Giuseppe Remuzzi; Marina Noris
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

6.  Mathematical Modelling of Alternative Pathway of Complement System.

Authors:  Suruchi Bakshi; Fraser Cunningham; Eva-Maria Nichols; Marta Biedzka-Sarek; Jessica Neisen; Sebastien Petit-Frere; Christina Bessant; Loveleena Bansal; Lambertus A Peletier; Stefano Zamuner; Piet H van der Graaf
Journal:  Bull Math Biol       Date:  2020-02-15       Impact factor: 1.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.